Gower, Emily W <br/><br/>
Geographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States.  [electronic resource] 

 -  American journal of ophthalmology  Dec 2017 
 - 157-166 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-1891 
<br/><br/><label>Standard No.: </label>10.1016/j.ajo.2017.10.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--administration & dosage<br/>Bevacizumab--administration & dosage<br/>Female<br/>Humans<br/>Intravitreal Injections<br/>Male<br/>Prevalence<br/>Ranibizumab--administration & dosage<br/>Retrospective Studies<br/>United States--epidemiology<br/>Visual Acuity<br/>Wet Macular Degeneration--diagnosis